In congressional testimony, Michael Cohen sketched out a relationship that contradicts Novartis’ original version in some important ways—namely, regarding how often the company interacted with Cohen and what, exactly, Novartis wanted him to do. More: BREAKING: Cohen drops testimony on
read moreThe FDA keeps rolling through the Indian manufacturing plants of Dr. Reddy’s Laboratories and the Form 483s keep falling out. More: Dr. Reddy's solid dose plant pinched by FDA for missteps Source: fierce
read moreBayer’s Xarelto and Eylea are still the top performers within the company’s pharma business. But both drugs are looking at a bumpy road ahead. More: With Bayer predicting slowdowns for Xarelto and Eylea, what will fill the gap? Source: fierce
read moreIn a high-stakes Humira patent fight, AbbVie persuaded a judge to force Boehringer Ingelheim to turn in its biosimilar launch plans. Because if BI is stockpiling for a rollout already, it’s also stepping on AbbVie’s patents. More: Hand over your
read moreThe FDA has issued guidance on continuous manufacturing and is allocating $58 million to move forward advanced manufacturing processes. More: Gottlieb throws FDA weight behind industry move to continuous manufacturing Source: fierce
read moreGW Pharmaceuticals has reported revenue growth of 67.5% for the fourth quarter, driven by demand for Epidiolex. More: GW Pharmaceuticals announce quarterly financial results Source: News
read more© 1994 - 2026 B.M. Pharmaceuticals